Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis
نویسندگان
چکیده
منابع مشابه
Lung transplantation in cystic fibrosis.
Lung transplantation has become a viable option for those cystic fibrosis (CF) patients with end-stage lung disease. Despite the challenges that the CF patients present, the survival seen after lung transplantation is more favorable than seen in patients with chronic obstructive pulmonary disease and pulmonary fibrosis. Although the CF patients with severe respiratory disease usually are infect...
متن کاملInfections in patients with cystic fibrosis following lung transplantation.
BACKGROUND There is controversy over whether colonization with drug-resistant organisms is a contraindication to lung transplantation. METHODS We undertook a retrospective review of the results of lung transplantation for patients with cystic fibrosis (CF) at Duke University Medical Center. RESULTS As of May 1996, 21 patients with CF underwent bilateral lung transplantation. The first patie...
متن کاملInhaled colistin following lung transplantation in colonised cystic fibrosis patients.
Respiratory tract infections due to viral, bacterial or even fungal pathogens are common after lung transplantation [1]. Previous studies demonstrated increased hospitalisation rates and a greater risk of chronic lung allograft dysfunction in colonised patients with cystic fibrosis (CF) [2]. Positive effects of inhaled antibiotics have been demonstrated for pneumonia in non-transplant patients ...
متن کاملHyperacute rejection following lung transplantation.
Although hyperacute rejection has been clinically and pathologically fully described in recipients of other solid organ transplants, to our knowledge, there have been no previous fully documented cases in recipients of lung transplants. This case of clinical hyperacute rejection is corroborated by a positive, donor-antigen-specific IgG-mediated lymphocytotoxic crossmatch (LXM), and demonstrated...
متن کاملCYSTIC FIBROSIS Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation
Background: WC and NS contributed equally. Non-tuberculous mycobacteria (NTM) frequently colonise patients with end stage cystic fibrosis (CF), but its impact on the course of the disease following lung transplantation is unknown. Methods: Lung transplant recipients with CF who underwent lung transplantation at our institution between January 1990 and May 2003 (n = 146) and CF patients awaiting...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cochrane Database of Systematic Reviews
سال: 2018
ISSN: 1465-1858
DOI: 10.1002/14651858.cd009421.pub4